Depemokimab has already shown its potential as a therapy for severe asthma in two other phase 3 trials – SWIFT-1 and SWIFT-2 ...

Co-hosted by Veronica Green, the aim was to bring attention to the importance of communicating both symptoms and feelings ...

In true form, BIO-Europe will mark its 30th anniversary in Stockholm, Sweden, from November 4-6, 2024. The Nordic region ...

Now, the FDA has added three new products to its list of medicines in short supply as a result of the plant being taken ...

The US regulator has said that compounders can continue to trade in tirzepatide products while it undertakes a review to ...

The once-weekly injectable joins one-shot haemophilia B gene therapy Beqvez (fidanacogene elaparvovec) in Pfizer’s portfolio, ...

US Senator Elizabeth Warren has asked the Federal Trade Commission (FTC) to look into a $16.5 billion deal that would give ...

The consultation on raising the threshold suggests that this change will “ensure that the BIT continues to target those ...

Artificial intelligence (AI) is an increasingly valuable tool in our perpetual quest for the miracles that science regularly ...

Sanofi said in October last year that it was planning to spin off its consumer health business into a separate company before ...

GSK said it expects to take a charge of £1.8 billion ($2.3 billion) in its third-quarter results in relation to the ...

Our round-up of recent biotech financings features a strong first round for City Therapeutics, a new RNAi venture led by ...